Home
Bergen Gynecologic Cancer Research Group

News archive for Bergen Gynecologic Cancer Research Group

Vimentin, component of the cytoskeleton, has so far been associated with epithelial-to-mesenchymal transition, increased metastatic potential and, hence, poor prognosis in many cancer types. However, our newest study indicates that its role in endometrial cancer might be opposite to what we believed thus far.
Fresh look on the protein expression of ERBB2 (HER2) in endometrial cancer.
European Society for Medical Oncology (ESMO) has held its annual Gynaecological Cancers Congress this year in Florence, Italy, 20-22nd June, 2024.
PhD student Hilde Lien wins second place at the Annual Research Presentations 2024 event hosted by the Research School in Clinical Medicine.
CCBIO PhD candidate Marta Espevold Hjelmeland in the Krakstad group spends the second year of her PhD program in Boston.
Mari Kyllesø Halle received a frame allocation of NOK 8 million in the Researcher Projects 2023 call from the Norwegian Cancer Association, for the project "Decoding the Landscape of Cancer Vulnerabilities in high-risk Cervical Carcinomas to detect new treatment strategies." CCBIO is proud to see this CCBIO Masterclass alumna as a project leader for the first time.
CCBIO postdoc får forskningspris i onkologi
Camilla Krakstad awarded with the Falch Junior Prize for young researchers